Showing results (171-180 of 187) with videos related to
Sort By:
Pageof 19
Archives of Neurology|February 15, 2001
Induction by dopamine D1 receptor agonist ABT-431 of dyskinesia similar to levodopa in patients with Parkinson diseaseO Rascol, J G Nutt, O Blin, et al.Annals of Neurology|September 11, 1999
Clinicopathological findings following intraventricular glial-derived neurotrophic factor treatment in a patient with Parkinson's diseaseJ H Kordower, S Palfi, E Y Chen, et al.Archives of Neurology|August 1, 1997
What is the accuracy of the clinical diagnosis of multiple system atrophy? A clinicopathologic studyI Litvan, C G Goetz, J Jankovic, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|July 11, 1998
Retrospective application of a set of clinical diagnostic criteria for the diagnosis of multiple system atrophyI Litvan, V Booth, G K Wenning, et al.Neurology|July 1, 1996
Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshopI Litvan, Y Agid, D Calne, et al.Neurology|July 1, 1997
What are the obstacles for an accurate clinical diagnosis of Pick's disease? A clinicopathologic studyI Litvan, Y Agid, N Sastry, et al.Archives of Neurology|July 25, 1998
Accuracy of the clinical diagnoses of Lewy body disease, Parkinson disease, and dementia with Lewy bodies: a clinicopathologic studyI Litvan, A MacIntyre, C G Goetz, et al.Neurology|December 7, 2007
FMR1 CGG repeat length predicts motor dysfunction in premutation carriersM A Leehey, E Berry-Kravis, C G Goetz, et al.European Journal of Neurology|January 23, 2014
Relationship between the MDS-UPDRS domains and the health-related quality of life of Parkinson's disease patientsP Martínez-Martín, C Rodríguez-Blázquez, M J Forjaz, et al.European Journal of Neurology|April 24, 2013
Assessing the non-motor symptoms of Parkinson's disease: MDS-UPDRS and NMS ScaleP Martinez-Martin, K R Chaudhuri, J M Rojo-Abuin, et al.Pageof 19